Prevention and Noninvasive Management of Coronary Atherosclerosis in Patients with Diabetes

Bourassa, M. and Berry, C. (2008) Prevention and Noninvasive Management of Coronary Atherosclerosis in Patients with Diabetes. Current Atherosclerosis Reports, 10(2), pp. 106-116. (doi:10.1007/s11883-008-0016-0)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1007/s11883-008-0016-0

Abstract

Diabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly increasing in both developing and developed countries. Coronary heart disease (CHD) is highly prevalent and is the major cause of morbidity and mortality in patients with diabetes. Individuals with prediabetes states, with or without known CHD, should undergo lifestyle modifications aimed at preventing DM. In patients with CHID and DM, routine use of aspirin and an angiotensin-converting enzyme inhibitor, along with strict glycemic, blood pressure, and lipid control, is strongly recommended. Intense insulin therapy may be needed for glycemic control, and high-dose statin therapy may be needed for lipid control. For blood pressure control, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are considered first-line therapy. Noncompliance with medications and/or lifestyle measures and, underprescription of evidence-based therapies remain important unsolved problems.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Berry, Professor Colin
Authors: Bourassa, M., and Berry, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:Current Atherosclerosis Reports
ISSN:1523-3804

University Staff: Request a correction | Enlighten Editors: Update this record